1
... 1 Universitätsspital Zürich Klinik für ORL Direktor: Prof. Dr. R. Probst Bereich Forschung Leiter ... ....................................................................................................................... 2 1. GLOSSAR ... 1 ... 1 Universitätsspital Zürich Klinik für ORL Direktor: Prof. Dr. R. Probst Bereich Forschung Leiter ... 1 ...
cobas® HIV-1｜ロシュ・ダイアグノスティックス
... 生化学者、学者およびその他の医学研究に関与している人 Your session has expired. Please log in again. cobas® HIV- 1 ・HIV- 1ゲノムの ... うち、薬剤耐性変異の起こりにくいgagとLTRの2つの領域をターゲットにしています。 ・変異型のHIV- 1も確実に検出できるため、見かけ上少ない値で報告される可能性を防ぎます。 Update ... 100%（ 95% 信頼区間 ≧99.5%） 検出ジェノタイプ HIV- 1グループM (A - D, F - H, CRF01_AE, CRF02_AG)、 グループO, 及びグループN *Not ... り抜けてしまう可能性があります 1, 2 。 HIV- 1の定量測定は 信頼できるデュアルターゲットアッセイで ロシュのデュアルターゲットアッセイは、感度、網羅性、安定性が向上した試薬を用いて効果的に ... cobas® HIV- 1｜ロシュ・ダイアグノスティックス ...
Microsoft Word - 05_2007101800709203_FullPaper_查.doc
... wavelength [nm] 1000900800700600500 leaf (PV) with ± 1 SD Cab (15− 95 μg/cm2) background bark (NPV) C V ... , Michael.Schaepman, Jan.Clevers)@wur.nl Commission VII, WG VII/ 1 KEY WORDS: Chlorophyll Content, Non-Photosynthetic ... wavelength [nm] 1000900800700600500 leaf (PV) with ± 1 SD Cab (15− 95 μg/cm2) background bark (NPV) C V ... , Michael.Schaepman, Jan.Clevers)@wur.nl Commission VII, WG VII/ 1 KEY WORDS: Chlorophyll Content, Non-Photosynthetic ... Microsoft Word - 05_2007101800709203_FullPaper_ 查.doc ...
Slide 1
... Slide 1 QUBIT READOUT ON OFF 0 1 QUBIT READOUT ON OFF 0 1 0 QUBIT READOUT ON OFF 1 0 1 Yale ... , and Schoelkopf, Phys. Rev. Lett. 95, 060501 (2005) Wallraff, Schuster, Blais, ... Girvin, Schoelkopf ... Slide 1 ... Slide 1 QUBIT READOUT ON OFF 0 1 QUBIT READOUT ON OFF 0 1 0 QUBIT READOUT ON OFF 1 0 1 Yale ... Slide 1 ...
Slide 1
... 3D-CAD Construction 42/69 3D-CAD Construction ( 1) ● Built to the Power Density Limit @ η= 95% / Tc ... Slide 1 1/69 1/150 Johann W. Kolar et al. ETH Zurich, Switzerland Power Electronic Systems ... 3D-CAD Construction 42/69 3D-CAD Construction ( 1) ● Built to the Power Density Limit @ η= 95% / Tc ... Slide 1 ... Slide 1 ...
Slide 1
... Slide 1 Delivery of Health Care at the End of Life in Cancer Patients from Four Swiss Cantons (SAKK ... 1,3), Matthias Schwenkglenks 1), Bernhard C. Pestalozzi 9) 1) Institute for Pharmaceutical Medicine ... Slide 1 ... Slide 1 Delivery of Health Care at the End of Life in Cancer Patients from Four Swiss Cantons (SAKK ... Slide 1 ...
Slide 1
... Slide 1 A retrospective database study investigating days spent in acute care hospitals during the ... with about 20% market share and patient record review identified 2086 patients, which had at least 1 ... Slide 1 ... Slide 1 A retrospective database study investigating days spent in acute care hospitals during the ... Slide 1 ...
Slide 1
... Mechanical Construction ( 1) ● Built to the Power Density Limit @ η= 95% / Tc < 60°C ■ 88.7mm x 88.4mm x 31mm ... Slide 1 Johann W. Kolar Swiss Federal Institute of Technology (ETH) Zurich Power Electronic Systems ... Mechanical Construction ( 1) ● Built to the Power Density Limit @ η= 95% / Tc < 60°C ■ 88.7mm x 88.4mm x 31mm ... Slide 1 ... Slide 1 ...
Folie 1
... Folie 1 Obesity as Prognostic Factor for Survival after Breast Cancer: Results from a population ... population-based studies (Ref. 1). Because adjustment for potential confounding was not consistent across ... Folie 1 ... Folie 1 Obesity as Prognostic Factor for Survival after Breast Cancer: Results from a population ... Folie 1 ...
Folie 1
... Folie 1 Stem Cell Transplantation for AL Amyloidosis Ute Hegenbart, MD Amyloidosis Center ... University Heidelberg Medical Dept. V / Hematology / Stem cell transplant Unit Zürich, 19.06.2014, 1 ... Folie 1 ... Folie 1 Stem Cell Transplantation for AL Amyloidosis Ute Hegenbart, MD Amyloidosis Center ... Folie 1 ...
